What is the appropriate management of iron deficiency anemia in a 35‑year‑old adult on a proton‑pump inhibitor (PPI) for dyspepsia?

Management of Iron Deficiency Anemia in a 35-Year-Old on PPI for Dyspepsia

Start oral iron replacement therapy immediately with one tablet daily of ferrous sulfate, fumarate, or gluconate (50-100mg elemental iron), and simultaneously pursue bidirectional endoscopy (gastroscopy and colonoscopy) to exclude underlying GI pathology—do not defer iron treatment while awaiting investigations. 1

Immediate Treatment Approach

Iron Replacement Therapy

• Begin oral iron immediately at one tablet per day (ferrous sulfate 200mg, fumarate, or gluconate) 1
• If not tolerated, reduce to alternate-day dosing or consider alternative preparations 1
• Continue for approximately 3 months after hemoglobin normalizes to replenish iron stores 1
• Monitor hemoglobin response at 4 weeks 1

Critical caveat: PPIs significantly impair oral iron absorption by reducing gastric acid, which is essential for converting ferric iron to the absorbable ferrous form 2, 3, 4. Studies show that 95% of PPI users with iron deficiency fail to respond adequately to oral iron 2, with mean hemoglobin increases of only 0.8 g/dL compared to expected rises >2 g/dL 4.

Consider PPI Management

The PPI itself may be causing or perpetuating the iron deficiency 2, 3, 5, 6:

• Evaluate if PPI can be discontinued or dose-reduced based on dyspepsia severity
• If PPI must continue, consider switching to an H2-receptor antagonist (famotidine), which has lower risk of iron malabsorption 6, 7
• If switching isn't possible, pantoprazole may have lower risk of iron deficiency compared to omeprazole or esomeprazole 8

Diagnostic Workup (Concurrent with Treatment)

Essential Investigations

Proceed with bidirectional endoscopy (gastroscopy and colonoscopy) as first-line investigations 1:

• At age 35, this patient requires evaluation for occult GI blood loss, malignancy, celiac disease, and other mucosal pathology
• Screen for celiac disease serologically or via small bowel biopsy during gastroscopy (found in 3-5% of IDA cases) 1
• Perform urinalysis to exclude renal tract bleeding 1

If Initial Workup is Negative

If bidirectional endoscopy is unrevealing AND the patient fails to respond adequately to oral iron:

• Capsule endoscopy is the preferred test for small bowel evaluation 1
• Consider CT/MR enterography as complementary investigation 1
• Reassess renal tract 1

When to Switch to Parenteral Iron

Consider intravenous iron if:

• Oral iron is not tolerated despite dose adjustment 1
• No hemoglobin response after 4 weeks of adequate oral therapy 1
• Patient continues on PPI with documented poor absorption 2, 4

The evidence strongly suggests that 95% of PPI-associated iron deficiency responds to intravenous iron when oral therapy fails 2. Options include iron sucrose, ferric carboxymaltose, or iron dextran, with appropriate monitoring for infusion reactions 1, 9.

Long-term Monitoring

• Recheck complete blood count at 4 weeks to assess response 1
• After normalization, monitor every 6 months initially to detect recurrence 1
• If IDA recurs despite negative initial workup, pursue small bowel investigation 1
• Long-term iron replacement may be necessary if the cause is irreversible (e.g., continued PPI requirement) 1

Key Clinical Pitfalls

1. Don't delay iron treatment waiting for endoscopy results—treatment and investigation should occur simultaneously 1
2. Don't assume oral iron will work in PPI users—have a low threshold for switching to IV iron if no response at 4 weeks 2, 4
3. Don't overlook the PPI as the culprit—this is an under-recognized cause of refractory iron deficiency 2, 5
4. Don't stop investigating if first endoscopy is negative and patient doesn't respond to treatment—small bowel pathology must be excluded 1